## IEX: IDEX Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 2.2% below STRENGTH zone (3.0-6.0%); PEG 1.71 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($174.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Citi Maintains IDEX Corp(IEX.US) With Buy Rating, Maintains Target Price $202**
- Source: 富途牛牛 | 20251209T180848 | Bullish | Relevance: 97%
-  Citi analyst Vlad Bystricky has maintained a Buy rating for IDEX Corp (IEX.US) and kept the target price at $202. According to TipRanks data, this analyst has a 60.8% success rate and an average return of 10.8% over the past year. The information provided is for informational purposes only and not investment advice.

**2. AAR and Air France-KLM complete formation of aircraft nacelle JV in Asia**
- Source: Investing.com | 20251210T130835 | Neutral | Relevance: 73%
-  AAR Corp. and Air France Industries KLM Engineering & Maintenance (AFI KLM E&M) have successfully formed a joint venture called xCelle Asia in Thailand, following regulatory approval. This new facility in Chonburi will specialize in maintenance, repair, and overhaul services for aircraft nacelles, initially focusing on GEnx, Trent1000, and LEAP-1A/1B engine types in the Asia-Pacific region. The partnership aims to enhance their presence in the growing Asian aviation market, leveraging AAR’s component services expertise and AFI KLM E&M’s global network.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $202 | $197 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.10M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-1.1%)
- Wellington Managemen: 8.6% (+3.4%)
- Blackrock Inc.: 7.6% (-1.8%)
- Morgan Stanley: 4.5% (+7.6%)
- State Street Corpora: 4.2% (+1.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +2.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.71 elevated, pricing in significant growth expectations. Forward P/E 21.8x stretched relative to 5% growth. Balance sheet: strong liquidity (2.9x). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.6B |
| Beta | 1.00 |
| 52W Range | $153.36 - $228.88 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.71 |
| Forward P/E | 21.8 |
| Current P/E | 23.0 |
| YoY Growth | 5.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.0% to 2.2% (+2.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.8pp (needs >3.0% for momentum thesis). MRS_5 at 2.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.57), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.22% (CS: 63) | Neutral |
| RSI_14 | 67.4 | Neutral |
| MACD Histogram | 0.57 | Bullish |
| vs SMA20 | 1.055x | Above |
| vs SMA50 | 1.073x | Above |
| vs SMA200 | 1.045x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $181.24
- **Stop Loss:** $174.22 (3.9% risk)
- **Target:** $188.26 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 196
- **Position Value:** $35,523.04
- **Portfolio %:** 35.52%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-03 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.93 | $2.03 | +5.2% |
| 2025Q2 | $1.99 | $2.07 | +4.0% |
| 2025Q1 | $1.64 | $1.75 | +6.7% |
| 2024Q4 | $2.03 | $2.04 | +0.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*